Journal Information

Statistics

Follow this link to access the full text of the article

Análisis coste-utilidad del tratamiento de la esclerosis múltiple remitente-recidivante con acetato de glatiramero o interferón beta en España
C. RUBIO-TERRÉSa, I. ARÍSTEGUI RUIZb, F. MEDINA REDONDOc, G. IZQUIERDO AYUSd
a HERO Consulting. Madrid
b Departamento Científico. Aventis Pharma, S.A. Madrid
c Servicio de Farmacia. Servicio de Neurología. Hospital Universitario Virgen Macarena. Sevilla.
d Unidad de Esclerosis Múltiple. Servicio de Neurología. Hospital Universitario Virgen Macarena. Sevilla.
Read
5872
Times
was read the article
2174
Total PDF
3698
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 20 13 33
2025 April 62 35 97
2025 March 49 44 93
2025 February 48 31 79
2025 January 31 37 68
2024 December 36 31 67
2024 November 33 48 81
2024 October 47 43 90
2024 September 86 35 121
2024 August 39 56 95
2024 July 51 70 121
2024 June 67 67 134
2024 May 43 23 66
2024 April 91 33 124
2024 March 76 33 109
2024 February 69 37 106
2024 January 54 39 93
2023 December 53 39 92
2023 November 58 39 97
2023 October 58 31 89
2023 September 39 28 67
2023 August 29 15 44
2023 July 43 24 67
2023 June 43 13 56
2023 May 59 11 70
2023 April 32 9 41
2023 March 22 15 37
2023 February 66 18 84
2023 January 32 14 46
2022 December 20 12 32
2022 November 27 22 49
2022 October 16 13 29
2022 September 19 13 32
2022 August 23 33 56
2022 July 24 10 34
2022 June 18 10 28
2022 May 20 13 33
2022 April 20 15 35
2022 March 26 13 39
2022 February 26 11 37
2022 January 22 7 29
2021 December 23 15 38
2021 November 28 18 46
2021 October 29 24 53
2021 September 14 11 25
2021 August 14 6 20
2021 July 24 7 31
2021 June 30 15 45
2021 May 14 26 40
2021 April 79 19 98
2021 March 34 12 46
2021 February 15 11 26
2021 January 18 13 31
2020 December 16 10 26
2020 November 12 12 24
2020 October 6 29 35
2020 September 9 20 29
2020 August 10 13 23
2020 July 8 17 25
2020 June 8 9 17
2020 May 12 13 25
2020 April 18 19 37
2020 March 12 26 38
2020 February 5 5 10
2020 January 5 11 16
2019 December 13 15 28
2019 November 6 4 10
2019 October 15 3 18
2019 September 25 11 36
2019 August 11 10 21
2019 July 24 11 35
2019 June 58 29 87
2019 May 103 58 161
2019 April 56 20 76
2019 March 9 14 23
2019 February 15 7 22
2019 January 11 4 15
2018 December 12 12 24
2018 November 19 11 30
2018 October 30 15 45
2018 September 23 9 32
2018 August 2 5 7
2018 July 2 10 12
2018 June 5 3 8
2018 May 4 9 13
2018 April 3 8 11
2018 March 4 6 10
2018 February 2 5 7
2018 January 3 7 10
2017 December 7 11 18
2017 November 7 4 11
2017 October 9 12 21
2017 September 4 12 16
2017 August 4 3 7
2017 July 3 17 20
2017 June 7 20 27
2017 May 9 9 18
2017 April 24 6 30
2017 March 28 34 62
2017 February 16 10 26
2017 January 8 5 13
2016 December 22 7 29
2016 November 24 6 30
2016 October 27 11 38
2016 September 17 9 26
2016 August 20 5 25
2016 July 17 4 21
2016 June 20 14 34
2016 May 18 21 39
2016 April 15 11 26
2016 March 16 15 31
2016 February 7 6 13
2016 January 15 12 27
2015 December 8 9 17
2015 November 15 8 23
2015 October 21 11 32
2015 September 14 9 23
2015 August 18 15 33
2015 July 14 27 41
2015 June 6 10 16
2015 May 7 6 13
2015 April 5 3 8
2015 March 5 1 6
2015 February 4 3 7
2015 January 14 0 14
2014 December 24 4 28
2014 November 22 2 24
2014 October 16 1 17
2014 September 15 5 20
2014 August 17 3 20
2014 July 21 2 23
2014 June 26 2 28
2014 May 14 2 16
2014 April 14 2 16
2014 March 20 1 21
2014 February 12 1 13
2014 January 20 2 22
2013 December 13 3 16
2013 November 17 3 20
2013 October 15 2 17
2013 September 12 13 25
2013 August 16 5 21
2013 July 20 5 25
2003 April 314 0 314
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.